Battle Biotech
A systemic sweep to clear herpesvirus-infected cells.
Battle Biotech is a pre-clinical research-stage biotechnology company developing novel therapies that remove herpesvirus-infected cells.
Human herpesviruses are nearly universal, and their broad cellular tropism and multiple routes of transmission let them persist in reservoirs throughout the body. Reaching and clearing those infected cells calls for an approach beyond anything currently disclosed — which is what Battle Biotech is building.
Founded and led by CEO Dr. Richelle Cutler. Full therapeutic methodology will be disclosed following patent filing.
Explore
Programs
Herpesvirus Therapies
The therapeutic rationale, our issued and pending patents, and how the approach works.
View therapies →Science
The Science & Research
The working hypothesis, the research program, and Dr. Cutler’s background.
Explore the science →Publication
Oskar Fischer Prize Entry
The full paper: herpesviruses as a non-genetic driver of Alzheimer’s disease.
Read the paper →Evaluation
Scientific Analysis
An independent evaluation of the hypothesis, scored against the prize criteria.
Read the analysis →